Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity

Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity

Influenza is a common respiratory infectious disease. In China, Lianhua Qingwen capsule (LHQWC), a drug with significant clinical efficacy and few side effects, is commonly used to treat influenza. However, the composition of LHQWC is complicated, and currently used quality control methods cannot en...

Full description

Bibliographic Details
Main Authors: Yongfeng Zhou, Ming Niu, Dingkun Zhang, Zhenxing Liu, Qinghua Wu, Jiang Chen, Haizhu Zhang, Ping Zhang, Jin Pei
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Pharmacology
Subjects:
Lianhua Qingwen capsule
quality marker
biological activity
network pharmacology
UPLC
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.648439/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.648439/full

Similar Items